| 2008 |
Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. May 15, 2008;473(2):139-146. |
41 |
41 |
| 2020 |
Xing L, Ebetino FH, Boeckman RK Jr, Srinivasan V, Tao J, Sawyer TK, Li J, Yao Z, Boyce BF. Targeting anti-cancer agents to bone using bisphosphonates. Bone. September 2020;138:115492. |
4 |
2 |
| 2020 |
Wang H, Zhang H, Srinivasan V, Tao J, Sun W, Lin X, Wu T, Boyce BF, Ebetino FH, Boeckman RK Jr, Xing L. Targeting bortezomib to bone increases its bone anabolic activity and reduces systemic adverse effects in mice. J Bone Miner Res. February 2020;35(2):343-356. |
4 |
1 |
| 2020 |
Li J, Yi X, Yao Z, Chakkalakal JV, Xing L, Boyce BF. TNF receptor‐associated factor 6 mediates TNFα‐induced skeletal muscle atrophy in mice during aging. J Bone Miner Res. August 2020;35(8):1535-1548. |
1 |
1 |
| 2022 |
Tao J, Srinivasan V, Yi X, Zhao Y, Zhang H, Lin X, Zhou X, Boyce BF, Villalta PW, Ebetino FH, Ho KK, Boeckman RK Jr, Xing L. Bone-targeted bortezomib inhibits bortezomib-resistant multiple myeloma in mice by providing higher levels of bortezomib in bone. J Bone Miner Res. April 2022;37(4):629-642. |
0 |
0 |